- Home
- Publications
- Publication Search
- Publication Details
Title
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-06-16
DOI
10.3389/fimmu.2022.915837
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allogeneic CD20‐targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B‐cell lymphoma models
- (2022) Kevin P Nishimoto et al. Clinical & Translational Immunology
- Overcoming the challenges associated with CD3+ T-cell redirection in cancer
- (2021) Ajit Singh et al. BRITISH JOURNAL OF CANCER
- A bispecific single domain antibody boosts autologous Vγ9Vδ2-T cell responses towards CD1d in chronic lymphocytic leukemia
- (2021) Iris de Weerdt et al. CLINICAL CANCER RESEARCH
- Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia
- (2021) Rajkumar Ganesan et al. LEUKEMIA
- Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
- (2021) Nikhil C. Munshi et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
- (2021) Yang Li et al. Frontiers in Immunology
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- The state of the art of bispecific antibodies for treating human malignancies
- (2021) Shuhang Wang et al. EMBO Molecular Medicine
- BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells
- (2021) Carla E. Cano et al. Cell Reports
- Induced Pluripotent Stem Cell-Derived Gamma Delta CAR-T Cells for Cancer Immunotherapy
- (2021) Mark A Wallet et al. BLOOD
- Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response
- (2021) Aude De Gassart et al. Science Translational Medicine
- A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas
- (2021) Lawrence S. Lamb et al. Scientific Reports
- Gamma delta TCR anti-CD3 bispecific molecules (GABs) as novel immunotherapeutic compounds
- (2021) Eline van Diest et al. Journal for ImmunoTherapy of Cancer
- Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
- (2021) Amani Makkouk et al. Journal for ImmunoTherapy of Cancer
- Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
- (2020) Marc Rigau et al. SCIENCE
- Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia
- (2020) Tania Jain et al. Therapeutic Advances in Hematology
- The BiTE (Bispecific T‐Cell engager) platform: Development and future potential of a targeted immuno‐oncology therapy across tumor types
- (2020) Hermann Einsele et al. CANCER
- Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
- (2020) Mohindar M. Karunakaran et al. IMMUNITY
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumoral γδ T‐cell infiltrates, CCL4/5 protein expression and survival in patients with hepatocellular carcinoma
- (2020) Na Zhao et al. HEPATOLOGY
- Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
- (2020) Meir Rozenbaum et al. Frontiers in Immunology
- Electroporation of NKG2D RNA CAR Improves Vγ9Vδ2 T Cell Responses against Human Solid Tumor Xenografts
- (2020) Wei Xia Ang et al. Molecular Therapy-Oncolytics
- Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
- (2020) Yan Xu et al. Cellular & Molecular Immunology
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- High Abundance of Intratumoral γδ T Cells Favors a Better Prognosis in Head and Neck Squamous Cell Carcinoma: A Bioinformatic Analysis
- (2020) Huanzi Lu et al. Frontiers in Immunology
- Non-signaling Chimeric Antigen Receptors Enhance Antigen-Directed Killing by γδ T Cells in Contrast to αβ T Cells
- (2020) Lauren C. Fleischer et al. Molecular Therapy-Oncolytics
- Adoptive transfer of zoledronate-expanded autologous Vγ9Vδ2 T-cells in patients with treatment-refractory non-small-cell lung cancer: a multicenter, open-label, single-arm, phase 2 study
- (2020) Kazuhiro Kakimi et al. Journal for ImmunoTherapy of Cancer
- Bispecific antibodies: a mechanistic review of the pipeline
- (2019) Aran F. Labrijn et al. NATURE REVIEWS DRUG DISCOVERY
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors
- (2019) Hans‐Heinrich Oberg et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Large-scale expansion of Vγ9Vδ2 T cells with engineered K562 feeder cells in G-Rex vessels and their use as chimeric antigen receptor–modified effector cells
- (2018) Lin Xiao et al. CYTOTHERAPY
- Gamma-delta (γδ) T cells: friend or foe in cancer development?
- (2018) Yijing Zhao et al. Journal of Translational Medicine
- Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation
- (2018) Anna Capsomidis et al. MOLECULAR THERAPY
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- The structural basis of nanobody unfolding reversibility and thermoresistance
- (2018) Patrick Kunz et al. Scientific Reports
- Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
- (2018) Timm Hoeres et al. Frontiers in Immunology
- Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
- (2018) Vito Pistoia et al. Frontiers in Immunology
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook
- (2017) Mehdi Arbabi-Ghahroudi Frontiers in Immunology
- Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
- (2017) Jieti Wang et al. OncoImmunology
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
- (2017) Marie Tosolini et al. OncoImmunology
- Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
- (2017) S. Meraviglia et al. OncoImmunology
- A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells
- (2017) Renée C. G. de Bruin et al. OncoImmunology
- BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
- (2017) Audrey Benyamine et al. OncoImmunology
- Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy
- (2016) Hamid Reza Mirzaei et al. CANCER LETTERS
- Delta One T Cells for Immunotherapy of Chronic Lymphocytic Leukemia: Clinical-Grade Expansion/Differentiation and Preclinical Proof of Concept
- (2016) A. R. Almeida et al. CLINICAL CANCER RESEARCH
- Generation and characterization of CD1d-specific single-domain antibodies with distinct functional features
- (2016) Roeland Lameris et al. IMMUNOLOGY
- In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
- (2016) Joseph G. Pressey et al. MEDICINE
- γδ T cell activation by bispecific antibodies
- (2015) Hans-Heinrich Oberg et al. CELLULAR IMMUNOLOGY
- Human gamma delta T cells: Evolution and ligand recognition
- (2015) Erin J. Adams et al. CELLULAR IMMUNOLOGY
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- Tregs activated by bispecific antibodies
- (2015) Stefanie Koristka et al. OncoImmunology
- Ex vivoexpanded human circulating Vδ1 γδT cells exhibit favorable therapeutic potential for colon cancer
- (2015) Dang Wu et al. OncoImmunology
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- Successful adoptive transfer and in vivo expansion of haploidentical γδ T cells
- (2014) Martin Wilhelm et al. Journal of Translational Medicine
- Cytotoxic and Regulatory Properties of Circulating Vδ1+ γδ T Cells: A New Player on the Cell Therapy Field?
- (2014) Gabrielle M Siegers et al. MOLECULAR THERAPY
- Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
- (2014) Ikuo Wada et al. Cancer Medicine
- Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism
- (2014) Georg Gruenbacher et al. OncoImmunology
- Nanobodies: Natural Single-Domain Antibodies
- (2013) Serge Muyldermans Annual Review of Biochemistry
- Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
- (2013) D. T. Teachey et al. BLOOD
- Ex vivo characterization of γδ T-cell repertoire in patients after adoptive transfer of Vγ9Vδ2 T cells expressing the interleukin-2 receptor β-chain and the common γ-chain
- (2013) Takamichi Izumi et al. CYTOTHERAPY
- Crystal Structure of Vδ1 T Cell Receptor in Complex with CD1d-Sulfatide Shows MHC-like Recognition of a Self-Lipid by Human γδ T Cells
- (2013) Adrienne M. Luoma et al. IMMUNITY
- Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
- (2013) Jiuwei Cui et al. INTERNATIONAL JOURNAL OF CANCER
- Cutting Edge: CD1d Restriction and Th1/Th2/Th17 Cytokine Secretion by Human V 3 T Cells
- (2013) B. A. Mangan et al. JOURNAL OF IMMUNOLOGY
- Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor
- (2013) Drew C Deniger et al. MOLECULAR THERAPY
- Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy
- (2013) Lawrence S. Lamb et al. PLoS One
- Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human T-cell subset
- (2012) C. Harly et al. BLOOD
- Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL
- (2012) M. S. Topp et al. BLOOD
- Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy
- (2012) Volker Kunzmann et al. JOURNAL OF IMMUNOTHERAPY
- Farnesyl pyrophosphate synthase: a key enzyme in isoprenoid biosynthetic pathway and potential molecular target for drug development
- (2012) Manoj K. Dhar et al. New Biotechnology
- Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes
- (2012) Marco Donia et al. OncoImmunology
- Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
- (2011) A J Nicol et al. BRITISH JOURNAL OF CANCER
- Phase I/II study of adoptive transfer of γδ T cells in combination with zoledronic acid and IL-2 to patients with advanced renal cell carcinoma
- (2011) Hirohito Kobayashi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
- (2011) Joshua M. Lang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adoptive Immunotherapy for Advanced Non-small CellLung Cancer Using Zoledronate-expanded γδTCells
- (2011) Miki Sakamoto et al. JOURNAL OF IMMUNOTHERAPY
- Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
- (2010) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells☆☆☆
- (2010) Jun Nakajima et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
- (2009) Yu Abe et al. EXPERIMENTAL HEMATOLOGY
- Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
- (2008) Jaafar Bennouna et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started